LAUNXP Biomedical Co., Ltd (TPEX:6876)
Taiwan
· Delayed Price · Currency is TWD 19.90
-0.60 (-2.93%)
Apr 29, 2026, 2:00 PM CST
LAUNXP Biomedical Market Cap
LAUNXP Biomedical has a market cap or net worth of 665.32 million as of April 29, 2026. Its market cap has increased by 20.52% in one year.
Market Cap
665.32M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
19.90
Market Cap Chart
Since January 18, 2024, LAUNXP Biomedical's market cap has decreased from 721.03M to 665.32M, a decrease of -7.73%. That is a compound annual growth rate of -3.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 665.32M | -12.39% |
| Dec 31, 2025 | 759.44M | 11.55% |
| Dec 31, 2024 | 680.79M | -5.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiwanJ Pharmaceuticals | 626.55M |
| SynCore Biotechnology Co.,Ltd | 701.53M |
| Vectorite Biomedical | 623.74M |
| BioLASCO Taiwan | 755.55M |
| Neith | 793.51M |
| MegaPro Biomedical | 828.43M |
| NatureWise Biotech & Medicals | 897.75M |
| TCI GENE | 955.15M |